[1]Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593.
[2]Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4. PMID: 25651787.
[3]Hirano H, Boku N. The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma. Asia Pac J Clin Oncol. 2018 Aug;14(4):291-299. doi: 10.1111/ajco.12995. Epub 2018 Jun 5. PMID: 29873183.
[4]Kubo T, Ono S, Ueno H, Shinto E, Yamamoto J, Hase K. Impact of the perioperative neutrophil-to-lymphocyte ratio on the long-term survival following an elective resection of colorectal carcinoma. Int J Colorectal Dis. 2014 Sep;29(9):1091-9. doi: 10.1007 / s00384 -014 -1 964-1.Epub 2014 Jul 22. PMID: 25048875.
[5]Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002 Dec 19-26;420(6917):860-7. doi: 10.1038/nature01322. PMID: 12490959; PMCID: PMC2803035.
[6]Kühn T, Sookthai D, Graf ME, Schübel R, Freisling H, Johnson T, Katzke V, Kaaks R. Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study. Br J Cancer. 2017 Nov 7;117(10):1572-1579. doi: 10.1038/bjc.2017.313. Epub 2017 Sep 12. PMID: 28898231; PMCID: PMC5680462.
[7]McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009 May;12(3):223-6. doi: 10.1097/MCO.0b013e32832a7902. PMID: 19318937.
[8]Zhi X, Jiang K, Shen Y, Su X, Wang K, Ma Y, Zhou L. Peripheral blood cell count ratios are predictive biomarkers of clinical response and prognosis for non-surgical esophageal squamous cell carcinoma patients treated with radiotherapy. J Clin Lab Anal. 2020 Oct;34(10):e23468. doi: 10.1002/jcla.23468. Epub 2020 Jul 17. PMID: 32681567; PMCID: PMC7595892.
[9]Qingshan Z, Jing S, Nengchao W, Zhijie H, Qingfu Z, Lianjie F. Study of clinical staging of esophageal cancer treated by non-surgical methods. Can Res Prevent Treat. 2013;40(2):168-171.
[10]Gao Y, Guo W, Cai S, Zhang F, Shao F, Zhang G, Liu T, Tan F, Li N, Xue Q, Gao S, He J. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma. J Cancer. 2019 Jun 2;10(14):3188-3196. doi: 10.7150/jca.30281. PMID: 31289589; PMCID: PMC6603384.
[11]Shao Y, Ning Z, Chen J, Geng Y, Gu W, Huang J, Pei H, Shen Y, Jiang J. Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomy. Sci Rep. 2015 Dec 22;5:18811. doi: 10.1038/srep18811. PMID: 26689680; PMCID: PMC4686940.
[12]Liu JS, Huang Y, Yang X, Feng JF. A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma. Am J Cancer Res. 2015 Jun 15;5(7):2180-9. PMID: 26328248; PMCID: PMC4548329.
[13]Chang Y, An H, Xu L, Zhu Y, Yang Y, Lin Z, Xu J. Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma. Br J Cancer. 2015 Aug 11;113(4):626-33. doi: 10.1038/bjc.2015.241. Epub 2015 Jul 2. PMID: 26135896; PMCID: PMC4647686.
[14]Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Go H, Kim JE, Kim CW, Huh J. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. Oncologist. 2012;17(6):871-80. doi: 10.1634/theoncologist.2012-0034. Epub 2012 May 15. PMID: 22588324; PMCID: PMC3380887.
[15]Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006 Jan 27;124(2):263-6. doi: 10.1016/j.cell.2006.01.007. PMID: 16439202.
[16]Li Y, Liu W, Zhou Z, Ge H, Zhao L, Liu H, Song X, Wang D, Pei Q, Tan F. Development and validation of prognostic nomograms for early-onset locally advanced colon cancer. Aging (Albany NY). 2020 Dec 3;13(1):477-492. doi: 10.18632/aging.202157. Epub 2020 Dec 3. PMID: 33289705; PMCID: PMC7834989.
[17]Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012 Mar 15;12(4):298-306. doi: 10.1038/nrc3245. PMID: 22419253.
[18]Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, Welsh J, Cox JD, Crane CH, Hsu CC, Lin SH. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):128-135. doi: 10.1016/j.ijrobp.2017.05.037. Epub 2017 Jun 1. PMID: 28816138.
[19] Kobayashi N, Usui S, Kikuchi S, Goto Y, Sakai M, Onizuka M, Sato Y. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer. 2012 Feb;75(2):223-7. doi: 10.1016/j.lungcan.2011.06.009. Epub 2011 Jul 20. PMID: 21764477.
[20]Maltoni M, Amadori D. Prognosis in advanced cancer. Hematol Oncol Clin North Am. 2002 Jun;16(3):715-29. doi: 10.1016/s0889-8588(02)00024-2. PMID: 12170577.
[21]Arroyo V, García-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014 Aug;61(2):396-407. doi: 10.1016/j.jhep.2014.04.012. Epub 2014 Apr 18. PMID: 24751830.
[22]McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009 May;12(3):223-6. doi: 10.1097/MCO.0b013e32832a7902. PMID: 19318937.
[23]Ohori Tatsuo Gondo And Riu Hamada M, Gondo T, Hamada R. [Nomogram as predictive model in clinical practice]. Gan To Kagaku Ryoho. 2009 Jun;36(6):901-6. Japanese. PMID: 19542708.
[24]Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015 Apr;16(4):e173-80. doi: 10.1016/S1470-2045(14)71116-7. PMID: 25846097; PMCID: PMC4465353.